Moderna - Yahoo Search Results

- Why Moderna Could Be Worth $100 Billion Within 5 Years | The Motley Fool
  The Motley Fool· 2 hours ago
  There are only a dozen drugmakers in the world right now with market caps of $100 billion or more. ...
- Good news about the 'Moderna arm' vaccine rash — it's no worse with second shot
  USA TODAY via Yahoo News· 15 hours ago
  There's good news about "Moderna arm," the raised, sometimes itchy red rash some people get a week...
- Why Moderna Stock Is Sinking Again Today | The Motley Fool
  The Motley Fool· 19 hours ago
  Shares of Moderna (NASDAQ:MRNA) were sinking 7.2% lower as of 12:03 p.m. EST on Wednesday. It marked...
- No Surprise Here: Moderna's Revenue Skyrockets in Q4 | The Motley Fool
  The Motley Fool· 7 days ago
  Moderna (NASDAQ:MRNA) has announced its financial results every quarter since going public in late...
- Moderna COVID-19 Vaccine May Cause Alarming Delayed Side Effect, Doctors Say It's 'Normal'
  International Business Times· 8 hours ago
  Moderna’s coronavirus vaccine may cause alarming delayed side effects from its first dose among a...
- Moderna expects $18.4 billion in 2021 sales from Covid vaccine, chief medical officer to depart
  CNBC· 7 days ago
  Moderna said Thursday it expects to generate $18.4 billion in sales from its Covid-19 vaccine this...
- Researchers urge greater awareness of delayed skin reactions to Moderna COVID-19 vaccine
  Medical Xpress· 4 hours ago
  -CoV-2 virus ramps up globally, researchers at Massachusetts General Hospital (MGH) are calling for...
- Some Experience Delayed Rashes After Moderna Shots, Report Says
  Bloomberg· 15 hours ago
  About half also got skin reactions after the second dose, though they were less severe. The...
- Moderna to reap $18.4B off COVID-19 vaccines in 2021
  Fox Business· 7 days ago
  “2020 was a historic year for Moderna,” Stéphane Bancel, chief executive officer of Moderna, said over an earnings call. Advance purchase agreements were...
- Moderna COVID-19 vaccine trial in kids ages 12 to 17 hits full enrollment
  Fox News· 6 days ago
  Moderna has completed enrollment for a Phase 2/3 study of its COVID-19 vaccine in adolescents ages...